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Background: Previous studies suggested that apolipoprotein A5 (ApoA5) genetic polymorphisms (SNPs) may result
in lipid metabolism disorders. Therefore, genetic polymorphisms in ApoA5 may be associated with the occurrence
of osteonecrosis of femoral head (ONFH).
Methods: We designed a case ? control study including 223 patients of osteonecrosis and 201 age- and
sex-matched control subjects to analyze the association between ApoA5 polymorphisms and susceptibility of
steroid-induced ONFH. We utilized polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP)
method to genotype two SNPs (rs662799 and rs3135506) in ApoA5 gene.
Results: We found both rs662799 and rs3135506 were associated with the risk of ONFH in codominant, dominant,
and recessive model, respectively. Haplotype analyses suggested that T-C haplotype was associated with decreased
risk of ONFH, whereas the haplotype C-C was significantly associated with an increased risk of ONFH.
Conclusion: Our study suggested that ApoA5 genetic polymorphisms were associated with susceptibility to ONFH in
Chinese population. However, our results need further investigation with large sample size and various populations.
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13000_2014_229
Keywords: Apolipoprotein A5, Steroid-induced osteonecrosis, Gene polymorphismBackground
Osteonecrosis of femoral head (ONFH) is a kind of
orthopedic refractory disease that cellular death happens
within femoral head owing to damage of blood supply to
the anterior-superior-lateral part of the femoral head [1].
In China, there are approximately 7 million people with
ONFH currently. And, new cases reached to 100? 200
thousand each year [2]. ONFH is a complex disorder may
result from various risk factors such as trauma, alcohol-
ism, coagulation defects, and abnormal lipid metabolism.
Recent study suggested that abnormal lipid metabolism is
main pathogenesis of osteonecrosis [3]. Hyperlipidemia
affects the microcirculation of the femoral head to result
in femoral necrosis from multiple links, such as affecting
blood coagulation solvent systems, influencing bone fat* Correspondence: wuzhongyyan@yeah.net
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unless otherwise stated.embolism, and affecting the formation of bone micro-
thrombosis [4,5]. ApoA5 is an important apolipoprotein
which involved in plasma lipid metabolism. The most sig-
nificant impact on plasma triglycerides (TG) levels seems
to be associated with ApoA5 gene (ID 116519, OMIM
accession number 606368) variants [6,7]. ApoA5 is located
on TG-rich and high density lipoprotein (HDL) particles,
enhances the activity of lipoprotein lipase [7,8], and re-
combinant apoA5 binds to the LDL receptor family mem-
bers [9]. Previous studies suggested that minor alleles of
two SNPs (rs662799 and rs3135506) in ApoA5 gene were
associated with elevated plasma TG levels, regardless of
ethnicity and sex [10-13].
In 2007, Hirata et al. [14] found ApoB gene polymorph-
ism was associated with osteonecrosis. Subsequently,
Wang et al. [15] found -75G > A polymorphism in ApoAI
gene was associated with osteonecrosis in Chinese popula-
tion. Recently, Yin et al. also found SNPs in ApoAI geneis an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics of the participants
Groups N Age (years) Gender (M/F) BMI Kg/m2 GLU (mmol/L) TG (mmol/L) TC (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L)
ONFH group 223 42.27 ? 15.71 121/102 23.7 ? 3.5 5.8 ? 1.4 2.5 ? 1.1 5.3 ? 2.4 1.5 ? 0.7 2.9 ? 1.6
Control group 201 43.33 ? 15.02 112/89 23.9 ? 3.2 5.7 ? 1.2 1.4 ? 1.3 4.6 ? 2.1 1.4 ? 0.8 2.2 ? 1.4
P 0.703 0.654 0.261 0.352 <0.001 0.001 0.184 0.007
Note: BMI = Body mass index; GLU = Glucose; TC = Total cholesterol; LDL-C = Low-density lipoprotein-cholesterol; LDL-C = High-density
lipoprotein-cholesterol; TG = Triglycerides.
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[16]. However, the relation between the polymorphisms of
ApoA5 gene and ONFH has not been studied.
In the present study, we designed a case ? control study
to reveal the relation between ApoA5 genetic polymor-
phisms and ONFH in a Chinese population.
Subjects and methods
Ethics
The present study has been performed with the approval
of the ethics committee of the 5th Affiliated Hospital of
Xinjiang Medical University and was in compliance with
the Helsinki Declaration. The informed consents of the
study were collected from all the candidate subjects.
Subjects
All the patients were selected from January 2001 to
December 2013 in the 5th Affiliated Hospital of Xinjiang








TC + CC 9 (4.49)
Recessive








CG + GG 25 (12.49)
Recessive
CC + CG 196 (98.51)
CC 3 (1.49)the diagnostic criteria of osteonecrosis proposed in 1995
by Mont et al. [17]. Steroid-induced ONFH was defined
by a history of a mean daily dose of ≥ 16.6 mg or highest
daily dose of 80 mg of predinosolone equivalent within
1 year prior to the development of symptoms or radio-
logical diagnosis in asymptomatic cases [18-20]. All the
patients were confirmed by clinical diagnosis, double hip
X-ray image, CT scan or MRI examination. We included
223 patients with steroid-induced ONFH (case group,
121 men, 102 women; mean age: 42.27 ? 15.71 years)
and 201 patients who did not develop steroid-induced
ONFH (control group, 112 men, 89 women; mean age:
43.33 ? 15.02 years) following steroid administration for
the present study. The clinical characteristics of patients
in case and control groups were summarized in Table 1.
SNPs selection and genotyping
Two SNPs (rs662799 and rs3135506), which were re-
ported to be associated with plasma lipid level, in thePatients OR (95% CI) P value
146 (65.2) 1
30 (13.2) 10.33 (2.54-52.77) <0.001
47 (21.6) 15.32 (4.12-55.67) <0.001
146 (65.2) 1
77 (34.8) 12.11 (4.33-36.21) <0.001
176 (78.4) 1
47 (21.6) 13.33 (3.21-44.05) <0.001
159 (70.98) 1
32 (14.29) 1.43 (0.82-3.76) 0.088
33 (14.73) 12.11 (3.66-67.12) <0.001
159 (70.98) 1
65 (29.02) 3.01 (1.98-6.33) <0.001
191 (85.27) 1
33 (14.73) 12.22 (2.12-50.76) <0.001
Table 3 Distribution of haplotypes
Haplotype ONFH Control P OR (95% CI)
T-C 0.109 0.247 0.003 0.605 [0.430 ~ 0.852]
T-G 0.213 0.195 0.199 1.455 [0.796 ~ 4.905]
C-C 0.143 0.152 0.117 0.936 [0.811 ~ 1.982]
C-G 0.122 0.060 0.002 2.223 [1.144 ~ 3.361]
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were collected using a standard venipuncture technique
and EDTA-containing tubes. DNA was extracted from
peripheral vein blood leukocytes using a whole blood gen-
ome extraction kit (Beijing Boiteke Corporation, Beijing,
China). SNPs rs662799 and rs3135506 were genotyped
using PCR-RFLP as described in details elsewhere [21-23].
Briefly, polymerase chain reaction (PCR) was performed
in a volume of 25 ml containing 200 ng of genomic DNA.
The amounts of Mg2+, dNTP, and DNA polymerase
(Bangalore Genei, India) used in each reaction were
1.5 mM, 200 mM, and 1 U, respectively. The thermal
cycles started with 94?C for 4 min and were followed by
35 cycles of 94?C for 30 s, 55?C for 30 s, and 72?C for 30 s.
A total volume of 20 ul containing 20 U endonuclease was
added directly to the PCR product and digested at 37?C
overnight. After electrophoresis, the digested products
were visualized on a 3% polyacrylamide gel with ethidium
bromide staining.
Statistical analysis
Data were analyzed using SPSS 17.0 software package
(Chicago, IL, USA).The genotype and allele frequencies
were calculated by direct counting method. The differ-
ences of genotype and allele distributions between case
and control groups were compared using χ2 test, OR
value and its 95% CI was calculated according to χ2 test.
Normality was assessed by plotting the residuals. Statis-
tical significance was set at p <0.05.Table 4 Comparison of lipids levels between each genotype
rs662799
Parameters Groups TT TC/CC
TC (mg/dl) Case 5.0 ? 2.7 (n = 146) 5.2 ? 2.5 (n = 77)
Control 4.4 ? 2.1 (n = 192) 4.9 ? 2.4 (n = 9)
LDL-C (mg/dl) Case 2.6 ? 1.2 2.9 ? 1.3
Control 2.3 ? 1.3 2.5 ? 1.2
HDL-C (mg/dl) Case 1.8 ? 0.9 1.6 ? 0.7
Control 1.7 ? 1.0 1.6 ? 0.8
TG (mg/dl) Case 2.1 ? 1.4 2.7 ? 0.8
Control 1.7 ? 0.8 1.6 ? 1.1
Note: TC = Total cholesterol; LDL-C = Low-density lipoprotein-cholesterol; LDL-C = Hi
**P value for rs3135506.Results
Characteristics of participants
The characteristics of 223 patients and 201 control sub-
jects were shown in Table 1. After the statistical analysis,
there were no significant differences in the distribution of
age, sex, body mass index (BMI), GLU, and HDL-C be-
tween the two groups. However, there were significant dif-
ferences in TG, TC and LDL-C between these two groups.
Hardy-Weinberg equilibrium
The genotype distributions were in Hardy-Weinberg
equilibrium in both case group and control group (both
P > 0.05, data not shown).
Genotype and allele frequency distributions
These two SNPs had a strong association with ONFH in
all genetic models (As shown in Table 2).To determine
the extent of linkage disequilibrium (LD) between the
two polymorphisms, standardized LD coefficient D? and
r2 were calculated (D ? = 0.65, and r2 = 0.12).
Haplotype analysis of rs662799 and rs3135506
To examine the combined effect of the two SNPs
(rs662799 and rs3135506) in the ApoA5 gene, we con-
structed 4 haplotypes between the two SNPs. As shown in
Table 3, T-C haplotype was associated with decreased risk
of ONFH (P = 0.003, OR = 0.605 95% CI: 0.430 ~ 0.852),
whereas the haplotype C-G (P = 0.002, OR = 2.223; 95% CI:
1.144 ~ 3.361) was significantly associated with an increased
risk of ONFH. No significant association was observed
between the haplotype T-G and C-C and ONFH.
ApoA5 genetic polymorphisms and lipids levels
In addition, age and sex adjusted intergenotypic variations
in lipid levels with respect to apoA5 polymorphisms have
been summarized in Table 4. Rare C allele of rs662799
and G allele of rs3135506 carriers were associated with
higher levels of TG in ONFH patients (both P < 0.05).rs3135506
CC CG/GG P* P**
5.2 ? 2.6 (n = 159) 5.0 ? 2.2 (n = 65) 0.125 0.442
4.6 ? 2.3 (n = 176) 4.8 ? 2.1 (n = 25) 0.112 0.314
2.7 ? 1.1 2.6 ? 1.3 0.109 0.197
2.4 ? 1.1 2.5 ? 1.3 0.221 0.453
1.6 ? 0.8 1.7 ? 0.8 0.198 0.3381
1.6 ? 1.0 1.4 ? 0.8 0.332 0.143
2.0 ? 1.0 2.8 ? 0.9 0.013 0.024
1.8 ? 0.9 1.5 ? 1.1 0.435 0.174
gh-density lipoprotein-cholesterol; TG = Triglycerides; *P value for rs662799;
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In the present study, we found that in patients with
ONFH, C allele of rs662799 and G allele of rs3135506 in
apoA5 gene were significantly higher than that in the
control group, the T-C haplotype frequency was signifi-
cantly lower than that in the control group (P <0.0001)
and C-G haplotype was common in the control group.
This is the first study to clarify the relation between
ApoA5 polymorphism and ONFH.
The abnormal lipid metabolism and intravascular coagu-
lation composed the main pathogenesis of osteonecrosis
[3]. Hyperlipidemia affected the microcirculation of the
femoral head resulting in femoral necrosis from mul-
tiple links, such as affecting blood coagulation solvent
systems, influencing bone fat embolism, and affecting
the formation of bone micro-thrombosis [21,22].
Many evidences showed that ApoA5 gene is associated
with serum lipid levels [10]. Recent findings indicate
that ApoA5 could also influence cholesterol homeosta-
sis and probably could play a role in hypertriglyc-
eridemia [11]. In our study, we found polymorphisms of
ApoA5 gene are associated with TG levels. The carriers
with mutant alleles have higher levels of TG in the ONFH
patients. Therefore, we consider the mechanism of the
association of ApoA5 polymorphisms with ONFH may
resulting from lipids level changes caused by ApoA5 genetic
polymorphism.
Although we found a positive association between
ApoA5 polymorphisms and ONFH, the present study
was limited by the relatively small sample size. This may
have led to weak statistical significance and wide CIs
when estimating odds ratios. In addition, we did not
perform functional study of these two SNPs, which may
be another limitation of our study.
Conclusion
In conclusion, this study showed that ApoA5 poly-
morphism may be associated with ONFH in Han
Chinese population.
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